These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 33194798)
1. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy. Dong R; Bai M; Zhao J; Wang D; Ning X; Sun S Front Cell Infect Microbiol; 2020; 10():557368. PubMed ID: 33194798 [TBL] [Abstract][Full Text] [Related]
2. Expansion of Zhao J; Bai M; Ning X; Qin Y; Wang Y; Yu Z; Dong R; Zhang Y; Sun S J Am Soc Nephrol; 2022 Dec; 33(12):2276-2292. PubMed ID: 36041791 [TBL] [Abstract][Full Text] [Related]
3. Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies. Han S; Shang L; Lu Y; Wang Y Front Cell Infect Microbiol; 2022; 12():904401. PubMed ID: 35656030 [TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study. Hu X; Du J; Xie Y; Huang Q; Xiao Y; Chen J; Yan S; Gong Z; Ouyang S BMC Nephrol; 2020 Mar; 21(1):97. PubMed ID: 32169051 [TBL] [Abstract][Full Text] [Related]
5. The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns. Li J; Shen Y; Yan K; Wang S; Jiao J; Chi H; Zhong JC; Dong Y; Wang P J Transl Med; 2024 Aug; 22(1):773. PubMed ID: 39152439 [TBL] [Abstract][Full Text] [Related]
6. Gut and respiratory microbiota landscapes in IgA nephropathy: a cross-sectional study. Yuan X; Qing J; Zhi W; Wu F; Yan Y; Li Y Ren Fail; 2024 Dec; 46(2):2399749. PubMed ID: 39248406 [TBL] [Abstract][Full Text] [Related]
7. The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls. Shah NB; Nigwekar SU; Kalim S; Lelouvier B; Servant F; Dalal M; Krinsky S; Fasano A; Tolkoff-Rubin N; Allegretti AS Kidney360; 2021 Aug; 2(8):1261-1274. PubMed ID: 35369657 [TBL] [Abstract][Full Text] [Related]
8. Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population. Zhong Z; Tan J; Tan L; Tang Y; Qiu Z; Pei G; Qin W Int Immunopharmacol; 2020 Dec; 89(Pt B):107085. PubMed ID: 33068859 [TBL] [Abstract][Full Text] [Related]
9. [Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors]. Bao WH; Tang W Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):124-132. PubMed ID: 36718700 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy. Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862 [TBL] [Abstract][Full Text] [Related]
11. Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective. Sugurmar ANK; Mohd R; Shah SA; Neoh HM; Cader RA BMC Nephrol; 2021 Apr; 22(1):145. PubMed ID: 33882859 [TBL] [Abstract][Full Text] [Related]
12. Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome. Zhang J; Luo D; Lin Z; Zhou W; Rao J; Li Y; Wu J; Peng H; Lou T Microb Pathog; 2020 Oct; 147():104359. PubMed ID: 32599137 [TBL] [Abstract][Full Text] [Related]
13. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis. Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312 [TBL] [Abstract][Full Text] [Related]
14. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy. Chai L; Luo Q; Cai K; Wang K; Xu B BMC Nephrol; 2021 Jun; 22(1):209. PubMed ID: 34082732 [TBL] [Abstract][Full Text] [Related]
15. Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy. Gao L; Li H; Liu X; Li H; Li P; Lu W; Xie X; Lv J; Jin J Front Immunol; 2024; 15():1415026. PubMed ID: 39104521 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes. Dong Y; Chen J; Zhang Y; Wang Z; Shang J; Zhao Z Front Cell Infect Microbiol; 2022; 12():1059692. PubMed ID: 36569195 [TBL] [Abstract][Full Text] [Related]
17. Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome? He JW; Cui DF; Zhou XJ; Chen P; Li Y; Zhang X; Wang YN; Gan T; Liu LJ; Shi SF; Zhu L; Hou P; Lv JC; Zhang H Front Immunol; 2022; 13():846323. PubMed ID: 35359934 [TBL] [Abstract][Full Text] [Related]
18. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367 [TBL] [Abstract][Full Text] [Related]
19. Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling. Tan J; Dong L; Jiang Z; Tan L; Luo X; Pei G; Qin A; Zhong Z; Liu X; Tang Y; Qin W J Transl Med; 2022 Aug; 20(1):382. PubMed ID: 36038927 [TBL] [Abstract][Full Text] [Related]
20. Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy. Cai F; Zhou C; Jiao N; Liang X; Ye Z; Chen W; Yang Q; Peng H; Tang Y; Niu C; Zhao G; Wang Z; Zhang G; Yu X Microbiol Spectr; 2023 Jun; 11(3):e0520222. PubMed ID: 37227280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]